Patent intelligence · US
US 12097230
Method and composition for treating post operative conditions
Method and composition for treating post operative conditions
Patent details — US 12097230
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 24, 2024
- Expiration
- Sep 19, 2044
- Applicant
- Bright Green Corporation
- Claims
- 1
- CPC classes
- A61K, A61K31/05, A61K31/352, A61K36/185
Quick answer
US 12097230 (Method and composition for treating post operative conditions) is held by Bright Green Corporation. Status: granted. Granted Sep 24, 2024. Expires Sep 19, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Bright Green Corporation
- Grant date
- Expiration
- Claims
- 1
- CPC classes
- A61K, A61K31/05, A61K31/352, A61K36/185, A61K9/0095
More from Bright Green Corporation
Related pharmaceutical patents in our USPTO index.
-
US 12383631
Immune antigen specific IL-18 immunocytokines and uses thereof
granted -
US 12350120
Gum-protecting and teeth-whitening strip and preparation method thereof
granted -
US 12220447
Proteolytic enzyme composition
granted -
US 12215133
GIP and GLP-1 dual receptor agonist, pharmaceutical composition, and use
granted -
US 12173062
Modified TNF-α antibodies and uses thereof
granted -
US 12115136
Fortified CBD oil for treatment of PTSD
granted -
US 11925686
Materials for phototherapies of ophthalmic diseases
granted
Frequently asked questions
What is US patent 12097230?
US 12097230 (Method and composition for treating post operative conditions) is held by Bright Green Corporation. Status: granted. Granted Sep 24, 2024. Expires Sep 19, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12097230?
Bright Green Corporation is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 57 pharmaceutical patents for this assignee.
When does US 12097230 expire?
Our index shows an expiration date of Sep 19, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.